In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 122 for your search:
Cancer Type/Condition:  Prostate cancer
Stage/Subtype:  stage II prostate cancer
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-022, NCT01352598
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: Thin-1, NCT01379742
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB# 11-002288, NCT01365143
4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: R12-3104L, NCT01581749
5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: GU004-11, NCT01603420
7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000365458, FCCC-03028, NCT00084552
8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 05-043, NCT00116142
9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: 04-8-10, NCT00241384
10.

Phase: Phase III
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-4, NCT00243646
11.

Phase: Phase III
Type: Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-3, NCT00247312
12.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000526353, CALGB-90203, NCT00430183
13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 90
Sponsor: Other
Protocol IDs: 02-4407-V04, NCT00486499
14.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: FSI-003, NCT00772317
15.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GU002-10, NCT01230866
16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000701128, RTOG-0924, NCT01368588
17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 35 to 85
Sponsor: Other
Protocol IDs: EPROST-20100635, NCT01411332
18.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 35 to 85
Sponsor: Other
Protocol IDs: EPROST-20101056, NCT01411345
19.

Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 11-096, NCT01407263
20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PrTK03, NCT01436968
21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GU003-10, NCT01492972
22.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000727326, RTOG-1115, NCT01546987
23.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11-497, NCT01617161
24.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 35 to 85
Sponsor: Other
Protocol IDs: EPROST-20110491, NCT01794403
25.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCCC-062006-010, 062006-010, SCCC-0604122, NCT00547339, UMN-2006UC048
1     
New Search